|
RBM7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.169900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.583000E-04 |
| Normal-vs-Stage2 |
4.136400E-01 |
| Normal-vs-Stage3 |
2.998200E-02 |
| Normal-vs-Stage4 |
6.383400E-03 |
| Stage1-vs-Stage2 |
1.356200E-01 |
| Stage1-vs-Stage3 |
8.544600E-01 |
| Stage1-vs-Stage4 |
7.493600E-01 |
| Stage2-vs-Stage3 |
3.097600E-01 |
| Stage2-vs-Stage4 |
1.999040E-01 |
| Stage3-vs-Stage4 |
7.003800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.027100E-04 |
| Normal-vs-AfricanAmerican |
1.202240E-02 |
| Normal-vs-Asian |
8.935900E-03 |
| Caucasian-vs-AfricanAmerican |
6.404200E-01 |
| Caucasian-vs-Asian |
4.858600E-01 |
| AfricanAmerican-vs-Asian |
4.237200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.23739999999962E-05 |
| Normal-vs-Female |
4.394000E-01 |
| Male-vs-Female |
1.299780E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.862100E-03 |
| Normal-vs-Extreme_Weight |
6.22999999999596E-05 |
| Normal-vs-Obese |
6.351800E-02 |
| Normal-vs-Extreme_Obese |
1.757540E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.466400E-01 |
| Normal_Weight-vs-Obese |
1.855220E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.541000E-01 |
| Extreme_Weight-vs-Obese |
3.526300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.568000E-01 |
| Obese-vs-Extreme_Obese |
1.820560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.442400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.843600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.004200E-04 |
| Normal-vs-Age(81-100Yrs) |
8.3066000000076E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.927630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.009350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.520400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.724400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.597740E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.306200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.970400E-04 |
| Normal-VS-Type2 PRCC |
2.780100E-04 |
| Normal-VS-KIRP CIMP |
2.497200E-01 |
| Normal-VS-Unclassified PRCC |
2.476400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.029600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.270100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.142420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.554100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.445840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.952000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.46530000000456E-05 |
| Normal-vs-N1 |
2.937800E-01 |
| Normal-vs-N2 |
2.748000E-02 |
| N0-vs-N1 |
1.192420E-01 |
| N0-vs-N2 |
8.862800E-01 |
| N1-vs-N2 |
4.276800E-01 |
|
|
